library.onepin.app/primobolan-enanthate-methenolone-enanthate Peptide Education Library
Education only, not medical advice 21+ Every dose is an example to finalize with a licensed provider
Hormonal Anabolic-Androgenic SteroidNot FDA-approved · research compoundControlled substance

Primobolan Enanthate (Methenolone Enanthate)

Methenolone Enanthate · Primo E

300-400mg/week (men), 50-75mg/week (women) – 400-600 mg IM 1-2x weekly
InjectableDHT DerivativeNon-AromatizableLong-Ester

Methenolone enanthate, marketed as Primobolan Depot, is a long-ester injectable anabolic-androgenic steroid derived from dihydrotestosterone (DHT). Developed by Schering AG in the early 1960s, it has a long history of medical use in Europe and Japan for muscle wasting, osteoporosis, and anemia. It is considered one of the mildest injectable AAS - anabolic-to-androgenic ratio roughly 88:44-57 - with virtually no estrogenic activity and very low androgenic side-effect burden.

Quick Start
Route
IM (intramuscular)
Start low
300-400mg/week IM
Frequency
1-2x weekly
Timing
No fasting required

Starting dose. 300-400mg/week — (men), 50-75mg/week (women)

Split weekly total into 2 injections for stable levels (enanthate ester, ~7-10 day half-life). Compatible with other oil-based AAS in the same syringe. Higher doses required for visible effect due to mild activity - plan 400mg/week minimum for men.

Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.

Tiered Protocols · lowest first
Conservative start
300-400mg/week (men), 50-75mg/week (women) · IM (intramuscular) · 1-2x weekly
conservative starter
300-400mg/week (men), 50-75mg/week (women)
1-2x weekly
Expert
Lean Tissue Accretion
400-600 mg · IM · Weekly
anecdotal · community
DHT derivative. Does not aromatize. Known for very mild side effects but relatively weak anabolic potency compared to testosterone.
400-600 mg
Weekly
01

How it works

Methenolone binds the androgen receptor (AR) with modest affinity and drives protein synthesis and nitrogen retention. As a DHT derivative, it does not aromatize to estrogen and has no intrinsic estrogenic activity.

Unusually for an AAS, methenolone exhibits relatively weak HPT-axis suppression at low-to-moderate doses - endogenous testosterone production is reduced but often not completely shut down. At higher bodybuilding doses (400mg+/week), full suppression does occur and a testosterone base is standard.

It is not 17-alpha-alkylated (rare for a DHT derivative used orally - the oral Primobolan tablets are 17-methylated, a less hepatotoxic modification; the injectable enanthate form bypasses the liver almost entirely). As a result it has a very mild side-effect profile - particularly low androgenic burden, minimal lipid shift, and low virilization risk in women compared to other AAS.

The enanthate ester gives a plasma half-life of ~7-10 days, supporting weekly or 2x-weekly injections.

02

What to expect

Early
Days 1–7

First 3 weeks: little to no visible effect. Some users report slight mood improvement. Steady state takes time.

Mid
Weeks 2–4

Weeks 4-8: subtle but steady lean mass preservation, improved muscle hardness. Not dramatic - primobolan is a 'quality over quantity' compound.

Later
Weeks 4–12

Weeks 9-12: sustained conditioning, maintained lean mass in deficit. Diminishing return beyond 12 weeks.

03

Evidence

HumanPresent
AnimalPresent
In-vitroPresent

References for this compound are being re-checked against their source records. We are not showing them until each one is confirmed to support the claim it sits under.

04

Side effects & safety

Commonly reported

  • Minimal - one of the lowest side-effect AAS
  • Modest HPT-axis suppression (dose-dependent)
  • Slight lipid shift (less severe than other AAS)
  • Possible accelerated hair loss in genetically predisposed users

Less common & notes

  • Oily skin, mild acne, minimal androgenic effects at lower doses.
  • Women tolerate primobolan better than most AAS but still risk virilization at higher doses.
  • Rare: hepatic stress markers elevation (the injectable is not 17-aa and is generally considered non-hepatotoxic).
  • Cardiovascular effects minimal at moderate doses.
05

Pharmacokinetics

Illustrative plasma concentration · 38 d
Half-life
7-10 days
Peak · Tmax
3-5 days

Post-injection

Elimination
3-4 weeks
Bioavailability
~100%

IM (oil depot)

Duration of action
7-10 days

Per injection - supports 1-2x weekly dosing

Clearance

Hepatic metabolism. Renal excretion of metabolites.

Storage. Store at controlled room temperature (20-25°C / 68-77°F). Protect from light. Oil-based solution - do not refrigerate or freeze. Draw with a larger gauge needle and inject with a smaller one (18G draw, 23-25G inject). Keep out of reach of children and in a locked location - Schedule III controlled substance in the United States.

06

Regulatory status

Schedule III controlled substance in the United States under the Anabolic Steroids Control Act of 1990. Never FDA-approved for human use in the US. Remains approved in some European and Japanese jurisdictions under the Primobolan Depot brand (Bayer / Schering). Possession or distribution without a valid prescription is a federal offense in the United States.

Put it to work

Calculate, log & track

Open Primobolan Enanthate (Methenolone Enanthate) straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.

Open Primobolan Enanthate (Methenolone Enanthate) in the app →

Go deeper

The guide & community

The complete Primobolan Enanthate (Methenolone Enanthate) walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.

Join the community ↗
Open in app Community

Track it in OnePin. Log vials, draws, and protocols in the app.